SARS-CoV-2 Interstitial Pneumonia Treated With Tocilizumab in a Patient Affected by Classical Hodgkin Lymphoma

SARS-CoV-2 Interstitial Pneumonia Treated With Tocilizumab in a Patient Affected by Classical Hodgkin Lymphoma

Dettagli Bibliografici
Autori principali:	Chiara Rusconi, Giulio Cassanello, Anna Guidetti, Chiara Oltolini, Vincenzo Marasco, Lucio Morabito, Matteo Della Porta, Rodolfo Lanocita, Gabriele Papagni, Cristiana Carniti, Paolo Corradini
Natura:	Articolo
Lingua:	English
Pubblicazione:	Wiley 2020-10-01
Serie:	HemaSphere
Accesso online:	http://journals.lww.com/10.1097/HS9.0000000000000472

Documenti analoghi

P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
di: Chiara Rusconi, et al.
Pubblicazione: (2022-10-01)

P1070: DECISIONAL ROLE OF INTERIM PET IN RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA TREATED WITH BEGEV CHEMOTHERAPY AS FIRST SALVAGE
di: Chiara Rusconi, et al.
Pubblicazione: (2023-08-01)

P006: Clinical outcome of classical Hodgkin Lymphoma patients receiving systemic anti-lymphoma treatment during SARS-COV-2 positivity: Results from the chemo-covid study on behalf of fondazione italiana linfomi
di: Chiara Rusconi, et al.
Pubblicazione: (2022-10-01)

Safety of Tocilizumab on Rheumatoid Arthritis in Patients with Interstitial Lung Disease
di: Otsuji N, et al.
Pubblicazione: (2024-06-01)

Rapid Antibody Testing for SARS-CoV-2 in Asymptomatic and Paucisymptomatic Healthcare Professionals in Hematology and Oncology Units Identifies Undiagnosed Infections
di: Paolo Corradini, et al.
Pubblicazione: (2020-06-01)

Genetics of classical Hodgkin Lymphoma
di: Gianluca Schiavoni, et al.
Pubblicazione: (2018-06-01)

Journal Club: Efficacy of Tocilizumab in Early Systemic Sclerosis–Related Interstitial Lung Disease
di: Vivekanand Tiwari, et al.
Pubblicazione: (2022-02-01)

Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma
di: Paolo F. Caimi, et al.
Pubblicazione: (2021-10-01)

Immune checkpoint inhibitors in combination with radiotherapy as salvage treatment for relapsed/refractory classical Hodgkin lymphoma: A retrospective analysis in 12 patients
di: Elisa Lucchini, et al.
Pubblicazione: (2021-06-01)

Controversies in the Treatment of Classical Hodgkin Lymphoma
di: Dennis A. Eichenauer, et al.
Pubblicazione: (2018-10-01)

Classical Hodgkin’s Lymphoma Presenting as Erythroderma
di: Kumar Parimalam, et al.
Pubblicazione: (2022-11-01)

Tocilizumab modulates the activity of the classical and alternative complement pathways in rheumatoid arthritis patients
di: Iván Ferraz-Amaro, et al.
Pubblicazione: (2025-01-01)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
di: Ahmet Dogan
Pubblicazione: (2022-10-01)

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
di: Irene Biasoli, et al.
Pubblicazione: (2023-11-01)

P054: The Kinase CK2 is deregulated and targetable in classical Hodgkin Lymphoma
di: Andrea Visentin, et al.
Pubblicazione: (2022-10-01)

Evolution of drug therapy for classical Hodgkin lymphoma
di: N. Y. Samaneva, et al.
Pubblicazione: (2022-09-01)

CAR-T Cell Therapy for Classical Hodgkin Lymphoma
di: Mikalai Katsin, et al.
Pubblicazione: (2023-12-01)

Current directions in the treatment of classical Hodgkin lymphoma
di: Frank G. Keller, et al.
Pubblicazione: (2023-11-01)

Treatment Of Classical Hodgkin Lymphoma: The State Of The Art
di: Carmino Antonio de Souza, et al.
Pubblicazione: (2023-10-01)

Bone marrow involvement by classic Hodgkin lymphoma
di: Mohammad Barouqa, et al.
Pubblicazione: (2022-05-01)

Aberrant synaptophysin expression in classic Hodgkin lymphoma
di: Soyoung Im, et al.
Pubblicazione: (2022-11-01)

Bob-1 is expressed in classic Hodgkin lymphoma
di: Abd El All Howayda S
Pubblicazione: (2007-03-01)

Relapsed and refractory classical Hodgkin lymphoma immunotherapy
di: Kirill Lepik
Pubblicazione: (2020-10-01)

Composite follicular lymphoma and classic Hodgkin lymphoma
di: Han-Na Kim, et al.
Pubblicazione: (2022-01-01)

Update on tocilizumab in rheumatoid arthritis: a narrative review
di: Simone Parisi, et al.
Pubblicazione: (2025-02-01)

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
di: Rossella Talotta, et al.
Pubblicazione: (2018-06-01)

Tocilizumab (Actemra)
di: Martin Sheppard, et al.
Pubblicazione: (2017-09-01)

The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future
di: S. E. Richardson, et al.
Pubblicazione: (2011-01-01)

Hemophagocytic Lymphohistiocytosis in a Patient with Classical Hodgkin Lymphoma
di: G. Hyun, et al.
Pubblicazione: (2016-01-01)

Classic Hodgkin lymphoma-nodular sclerosis – case report
di: Mihaela Lebedenco, et al.
Pubblicazione: (2023-06-01)

Optimization of the first line treatment in classical Hodgkin's lymphoma
di: Pauline Brice
Pubblicazione: (2018-06-01)

Cell-Free DNA for the Management of Classical Hodgkin Lymphoma
di: Vincent Camus, et al.
Pubblicazione: (2021-03-01)

An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma
di: Isacco Ferrarini, et al.
Pubblicazione: (2023-02-01)

The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma
di: Lai C, et al.
Pubblicazione: (2019-12-01)

P014 (0098) CD47 IS EXPRESSED ON HODGKIN REED STERNBERG CELLS IN CLASSICAL HODGKIN LYMPHOMA
Pubblicazione: (2018-10-01)

Reed-Sternberg and Hodgkin cells in bone marrow aspirate from a classical Hodgkin lymphoma patient
di: Leonardo Rodrigues Oliveira, et al.
Pubblicazione: (2022-04-01)

P110: Outcome of high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) as first salvage treatment for relapsed or refractory classical Hodgkin Lymphoma (cHL) in the era of PET-adapted strategy among Italian centers
di: Simonetta Viviani, et al.
Pubblicazione: (2022-10-01)

Classical Hodgkin Lymphoma Presenting with Severe, Recurrent Hypothermic Episodes
di: Jonas Juul Hansen, et al.
Pubblicazione: (2018-01-01)

Severe Aplastic Anemia as First Manifestation of Classical Hodgkin Lymphoma
di: Cláudia L. Pedrosa, et al.
Pubblicazione: (2021-01-01)

Cerebellar involvement in classical Hodgkin’s lymphoma: A case report
di: Suyash Chinchanikar, et al.
Pubblicazione: (2024-09-01)